Innova Captab Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: INNOVACAP BSE: 544067

About Innova Captab Limited

No company profile on record yet.

Key facts

BSE symbol544067
NSE symbolINNOVACAP
ISININE0DUT01020
CINL24246MH2005PLC150371
Listing date29 Dec 2023
Fiscal year end31 Mar
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
AuditorJaspreet Dhawan & Associates (Jaspreet Singh Dhawan)
Registered office1513, 15th Floor, Satra Plaza CHS Ltd., Plot No. 19&20, Sector-19D, Vashi, Navi Mumbai, Sanpada, Thane, Maharashtra, India-400703

Financial performance

Full financials →
Fiscal yearMar 26Mar 25Mar 24
Total income (before exceptional items)1,314†975†—
Net profit84†8968

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
Jayant Vasudeo RaoExecutive DirectorJune 30, 2026
Manoj Kumar LohariwalaExecutive DirectorJune 30, 2026
Vinay LohariwalaExecutive DirectorJune 30, 2026
Mahendar KorthiwadaIndependent DirectorJune 30, 2026
Priyanka DixitIndependent DirectorJune 30, 2026
Shirish Gundopant BelapureIndependent DirectorJune 30, 2026
Sudhir Kumar BassiIndependent DirectorJune 30, 2026
Archit AggarwalNon-Executive DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.